Core Insights - Hefei Tianyao New Materials Technology Co., Ltd. has completed several million yuan in Series A financing, led by Houxue Capital, with participation from SMIC Capital and Guoyuan Fund [1] - The funds will primarily be used for expanding production lines, product research and development, and exploring overseas markets and downstream detector integration business [1] - Established in April 2020, the company focuses on the research, production, and sales of third-generation strategic semiconductor crystal materials, with core products being Cadmium Zinc Telluride (CdZnTe) substrates and devices [1] - The company is also expanding into high-end Indium Phosphide (InP) and Aluminum Nitride (AlN) compound semiconductor products, aiming to break the technological monopoly held by Europe, the United States, and Japan [1] - Revenue for Hefei Tianyao is projected to reach several million yuan in 2024, with expectations of doubling this year [1] Company Ownership - Pang Hao is the actual controller of the company, holding 58.92% of the shares [3] - Pang Hao currently serves as the chairman and general manager of the company [3]

Core Insights - Hefei Tianyao New Materials Technology Co., Ltd. has recently completed a multi-million A round financing led by Huxue Capital, with participation from SMIC Juyuan and Guoyuan Fund, aimed at expanding production lines and product development, as well as exploring overseas markets and downstream detector integration business [1] Company Overview - Established in April 2020, Hefei Tianyao is located in Hefei Economic Development Zone and focuses on the research, production, and sales of third-generation strategic semiconductor crystal materials [1] - The company's core products include Cadmium Zinc Telluride (CdZnTe) substrates and devices, and it is expanding into high-end Indium Phosphide (InP) and Aluminum Nitride (AlN) compound semiconductor products [1] - Hefei Tianyao aims to break the technological monopoly held by Europe, the United States, and Japan, striving for self-controlled high-end semiconductor materials [1] Market Development - Photon CT using CdZnTe and Cadmium Telluride as detector materials has officially entered clinical use [1] - From the beginning of 2025 to the end of July, Siemens Medical has won bids from nearly 10 medical institutions, totaling 475 million yuan, with a single unit price of nearly 50 million yuan [1] - The photon counting spectral CT independently developed by United Imaging Healthcare has been installed in Zhongshan Hospital and Ruijin Hospital, initiating clinical testing and medical research [1] Strategic Positioning - The company recognizes the opportunity presented by the next generation of radiation detection technology and aims to become a core supplier in this wave [1] - Currently, Hefei Tianyao's CdZnTe products have achieved small batch supply in the medical field and have sent samples to several leading medical manufacturers, with expectations to enter a volume production phase next year [1]